NEW YORK, September 30, 2015 /PRNewswire/ --
Equity Research Institute has initiated coverage on the
following equities: Express Scripts Holding Company (NASDAQ: ESRX),
Aetna Inc. (NYSE: AET), Cigna Corporation (NYSE: CI), Becton Dickinson and Company (NYSE: BDX), and
Laboratory Corporation of America Holdings (NYSE: LH). Free
research report on Express Scripts Holding can be accessed at
https://www.equityresearchinstitute.com/ESRX.pdf On Tuesday, September 29, 2015, the NASDAQ Composite
ended at 4,517.32, down 0.59%, the Dow Jones Industrial Average
edged 0.30% higher, to finish the day at 16,049.13, and the S&P
500 closed at 1,884.09, up 0.12%. The losses were broad based as
five out of nine sectors ended the session in negative. Register
for your complimentary reports at the links given below.
Express Scripts Holding Co.'s stock advanced 1.00%, to close the
day at $80.80. The stock recorded a
trading volume of 4.75 million shares, above its three months
average volume of 4.26 million shares. Over the last one month and
over the past three months, Express Scripts Holding Co.'s shares
have lost 4.33% and 9.15%, respectively. Furthermore, the stock has
declined 4.57% since the start of this year. The company's shares
are trading 6.04% below their 200-day moving average. Additionally,
Express Scripts Holding Co. traded at a PE ratio of 26.49 and has a
Relative Strength Index (RSI) of 36.51. Sign up and read the free
notes on ESRX at:
https://www.equityresearchinstitute.com/ESRX.pdf
On Tuesday, shares in Aetna Inc. recorded a trading volume of
3.95 million shares, higher than their three months average volume
of 3.44 million shares. The stock ended the day 0.96% higher at
$106.31. Shares of the company traded
at a PE ratio of 16.08. Aetna Inc.'s stock has lost 9.03% in the
last one month and 16.41% in the previous three months. However,
the stock has surged 20.56% on YTD basis. The company is trading
below its 50-day and 200-day moving averages by 8.04% and 1.26%,
respectively. Furthermore, shares of Aetna Inc. have an RSI of
35.19. The complimentary notes on AET can be downloaded in PDF
format at:
https://www.equityresearchinstitute.com/AET.pdf
Cigna Corp.'s stock edged 0.38% lower, to close Tuesday's
session at $132.50. The stock
recorded a trading volume of 2.10 million shares, below its three
months average volume of 2.31 million shares. Over the last one
month and the previous three months, Cigna Corp.'s shares have
declined 3.89% and 18.21%, respectively. However, the stock has
gained 28.80% since the start of this year. The company is trading
0.93% above its 200-day moving average. Furthermore, Cigna Corp.'s
stock traded at a PE ratio of 16.56 and has an RSI of 33.82.
Register for free on Equity Research Institute and access the
latest research on CI at:
https://www.equityresearchinstitute.com/CI.pdf
Becton Dickinson and Co.'s stock
finished Tuesday's session 0.38% higher at $130.89. A total of 1.45 million shares were
traded, which was above its three months average volume of 1.14
million shares. Over the last one month and the previous three
months, Becton Dickinson and Co.'s
shares have lost 7.96% and 7.19%, respectively. Additionally, the
stock has fallen by 4.74% since the beginning of 2015. The
company's shares are trading below their 50-day and 200-day moving
averages by 8.35% and 7.45%, respectively. Becton Dickinson and Co.'s stock traded at a PE
ratio of 32.00 and has an RSI of 31.82. The complete research on
BDX is available for free at:
https://www.equityresearchinstitute.com/BDX.pdf
On Tuesday, shares in Laboratory Corp. of America Holdings ended
the session 1.30% lower at $106.86.
The stock reported a trading volume of 1.89 million shares, above
its three months average volume of 1.05 million shares. Shares of
the company traded at a PE ratio of 23.13. Laboratory Corp. of
America Holdings' shares have lost 10.66% in the last one month,
11.85% in the previous three months and 0.96% on YTD basis. The
company is trading 11.46% below its 50-day moving average and
10.60% below its 200-day moving average. Moreover, shares of
Laboratory Corp. of America Holdings have an RSI of 20.57. Free
in-depth research on LH is available at:
https://www.equityresearchinstitute.com/LH.pdf
--
About Equity Research Institute:
Equity Research Institute ("ERI") produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. ERI has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ERI has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on sound investment judgment and publicly
available information which is believed to be reliable. The
Reviewer and the Sponsor have not performed any independent
investigations or forensic audits to validate the information
herein. Unless otherwise noted, any content outside of this
document has no association with the Author, the Reviewer, or the
Sponsor (collectively referred to as the "Production Team") in any
way. The Production Team is compensated on a fixed monthly basis
and do not hold any positions of interest in any of the securities
mentioned herein.
NO WARRANTY
ERI, the Author, the Reviewer and the Sponsor (collectively
referred to as the "Publishers") are not responsible for any error
which may be occasioned at the time of printing of this document or
any error, mistake or shortcoming. No liability is accepted by the
Publishers whatsoever for any direct, indirect or consequential
loss arising from the use of this document. The Publishers
expressly disclaim any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Additionally, the
Publishers do not (1) guarantee the accuracy, timeliness,
completeness or correct sequencing of the information, or (2)
warrant any results from use of the information. The included
information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ERI nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://www.equityresearchinstitute.com
RESTRICTIONS
ERI is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.equityresearchinstitute.com